Q3 EPS Forecast for Sintx Technologies Increased by Analyst

Sintx Technologies, Inc. (NASDAQ:SINT) – Analysts at Ascendiant Capital Markets increased their Q3 2026 EPS estimates for Sintx Technologies in a note issued to investors on Wednesday, September 30th. Ascendiant Capital Markets analyst E. Woo now anticipates that the company will post earnings per share of ($0.33) for the quarter, up from their prior estimate of ($0.54). Ascendiant Capital Markets currently has a “Buy” rating and a $12.50 target price on the stock. The consensus estimate for Sintx Technologies’ current full-year earnings is ($1.67) per share. Ascendiant Capital Markets also issued estimates for Sintx Technologies’ Q4 2026 earnings at ($0.32) EPS, Q1 2027 earnings at ($0.30) EPS, Q2 2027 earnings at ($0.31) EPS, Q3 2027 earnings at ($0.30) EPS, Q4 2027 earnings at ($0.30) EPS and FY2027 earnings at ($1.21) EPS.

Sintx Technologies (NASDAQ:SINT) last posted its quarterly earnings results on Tuesday, August 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.73) by ($0.02). Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The company had revenue of $0.45 million during the quarter, compared to analyst estimates of $0.46 million.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Sintx Technologies in a research report on Friday, July 17th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $9.50.

Sintx Technologies Price Performance

Shares of SINT stock opened at $2.17 on Tuesday. The firm has a fifty day moving average of $1.74 and a two-hundred day moving average of $2.02. Sintx Technologies has a 1-year low of $1.40 and a 1-year high of $4.64.

Sintx Technologies Company Profile

SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.

The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.